In these extraordinary times, CDMO's find themselves in the unique territory, helping to supply innovators with clinical trial materials intended for COVID-19 applications as well as managing tremendous pressure in delivering products with raw material and supply chain scarcity. Often, timing requirements for these urgent projects pose significant challenges to typical CDMO timelines. However, when forced to find a solution, there are some options available to CDMO managers that can bridge this potentially cavernous gap.
At Cambrex we follow a “Reverse Engineering Methodology” helping our customers during these challenging times to ensure that timely deliveries are secured as well as supply chain efficiency is safeguarded.
Join us for a live webcast that will showcase valuable case studies and new methodologies that can help the wider CDMO industry in tackling delays in project deliveries.
We will also cover our strategy to ensure the delivery of drugs to customers and patients in spite of the COVID-19 outbreak with additional issues such as raw material and re-homing issues.